bearish
QuantumPharm (Xtalpi) Pre-IPO - PHIP Updates - Strong Growth, Although Losses Continue to Pile Up
520 Views30 May 2024 06:00
QuantumPharm (QUP HK) (Xtalpi) is looking to raise US$200m in its upcoming Hong Kong IPO. In this note, we discuss QuantumPharm's PHIP updates.
What is covered in the Full Insight:
- QuantumPharm's Overview
- Customer Base Expansion
- Growth Translated to Sales
- Decreasing Reliance on Top Customers
- Financial Performance
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- QuantumPharm US$750m Lockup Expiry - Financial Investors Checked 35% of Stock into CCASS10 Dec 2024
- QuantumPharm IPO Trading - Lukewarm Insti Demand Combined with a Tight Float at Listing13 Jun 2024
- QuantumPharm IPO - Most of the Potential Has Already Been Baked In06 Jun 2024
- QuantumPharm (Xtalpi) Pre-IPO - The Negatives - Requires Deep Pockets to Fund Its Cash Burn27 Feb 2024
- QuantumPharm (Xtalpi) Pre-IPO - The Positives - Grand Ambitions to Open New Monetisation Channels26 Feb 2024
- QuantumPharm (XtalPi) Pre-IPO Tearsheet04 Dec 2023
x